Olanzapine
Product Images NDC 64725-0955

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64725-0955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (583f95c1 Figure 01)

Chemical structure diagram of Olanzapine, depicting its molecular arrangement with characteristic rings and atoms, consistent with its chemical identity.*

FDA Label Image

Label Image (64725 0955)

Label for Olanzapine 10 mg vial for suspension, repackaged by TYA Pharmaceuticals. The label includes prescription only designation, lot number placeholder, expiration date placeholder, manufacturer American Regent Inc., contact address in Tallahassee, FL, and a barcode. Dose is referred to the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.